Drug Patent Expirations in September 2010

DrugPatentWatch.com announces drug patent expirations in September 2010

Drug Patent Expirations in September 2010

Drug Patent Expirations in September 2010

*Drugs may be covered by multiple patents

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
MUSE	Vivus	alprostadil	5,242,391	Sep 7, 2010
ADVAIR DISKUS 100/50	Glaxosmithkline	fluticasone propionate; salmeterol xinafoate	RE40045	Sep 7, 2010
ADVAIR DISKUS 500/50	Glaxosmithkline	fluticasone propionate; salmeterol xinafoate	RE40045	Sep 7, 2010
ZINECARD	Pharmacia And Upjohn	dexrazoxane hydrochloride	5,242,901	Sep 7, 2010
ADVAIR HFA	Glaxosmithkline	fluticasone propionate; salmeterol xinafoate	RE40045	Sep 7, 2010
ADVAIR DISKUS 250/50	Glaxosmithkline	fluticasone propionate; salmeterol xinafoate	RE40045	Sep 7, 2010
DENAVIR	Novartis	penciclovir sodium	6,573,378	Sep 24, 2010
DENAVIR	Novartis	penciclovir sodium	5,075,445	Sep 24, 2010
NAROPIN	App Pharms	ropivacaine hydrochloride monohydrate	4,870,086	Sep 24, 2010
ACCOLATE	Astrazeneca	zafirlukast	4,859,692	Sep 26, 2010
ACCOLATE	Astrazeneca	zafirlukast	5,583,152	Sep 26, 2010
AGGRASTAT	Medicure	tirofiban hydrochloride	5,658,929	Sep 27, 2010
AGGRASTAT	Medicure	tirofiban hydrochloride	5,880,136	Sep 27, 2010
FERIDEX I.V.	Amag Pharms Inc	ferumoxides	5,248,492	Sep 28, 2010
IMODIUM MULTI-SYMPTOM RELIEF	Mcneil	loperamide hydrochloride; simethicone	5,612,054	Sep 28, 2010

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin. Courtesy of DrugPatentWatch.com